The InfiniTrak team comes from an impressive range of backgrounds and education. Our diversity of disciplines and career paths ensures that our approach considers all angles. We know that DSCSA is, to say the least, a complex law and brings significant change to the way most pharmacies will track and trace their products. As the industry adopts the critical steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States, tools must be focused on efficiency.
For well over a decade, Mark Tate has "made a difference" in every community and every industry in which he has served. A self avowed giver and contributor in all aspects of his life, Mark has spent the bulk of his professional career working and coordinating with state and governmental officials to implement programs which benefit communities -- particularly in combating the opioid crisis. His expertise on DSCSA compliance and career networking with regulatory agencies have proved invaluable to InfiniTrak staying in forefront with ongoing regulations
As President of InfiniTrak, a company which develops these programs, he finds the dual approach of of creating the comprehensive technology solutions to fight the epidemic at the source of the crisis -- with programs to help those families most heavily affected by the crisis -- the overall solution. On a personal level, Mark and his wife give back by fostering five small children as part of the Foster Kids Program. Mark and InfiniTrak are currently working on proactive analytical solutions to track and trace opioids and other controlled substances to ultimately end the opioid crisis at its source. He is particularly proud of InfiniTrak's innovative solutions and robust data analytics that may actually uncover the next crisis of abuse BEFORE it begins its devastation of American families.
Chief Technology Officer
Partner and Chief Technology Officer at InfiniTrak. My team creates software that promotes innovative solutions that improve the saftey of the public, while reducing costs and increasing efficiency in both the public sector and healthcare space. Over the past few years, we have had the opportunity to expand beyond DSCSA and provide new solutions adding functionality to lower customer's costs as well as vastly improving efficiency.
InfiniTrak's flagship product has expanded over the years well beyond the initial independent pharmacists and hospital dispensaries that need a cost-effective solution to bolster their drug supply security. At that time it was an intuitive compliance solution for all aspects of the Drug Supply Chain Security Act (DSCSA). Since 2015, our technology has expanded to so many new and broader areas from law enforcement tools to predictive analytics for both the public and private sector.
Director of Implementation
Mary Zervos coordinates large scale implementation of InfiniTrak's compliance solutions for drug store chains and healthcare organizations.
She joined InfiniTrak in 2019 with the added functionality the company has developed beyond DSCSA to provide ROI to dispensers. She spent the prior 8 years at CVS Health and has built her 14 year career on increasing efficiency by tailoring processes to reduce time and cost in the healthcare arena.
Chief Financial Officer
Jason is the Chief Financial Officer for InfiniTrak 2.0 LLC; he focuses on the creation and development of operational and accounting expertise.
Jason has more than 12 years in the financial services industry. Under his tenure as a Shareholder, Director and Executive Committee Member at Strait Capital, assets under administration increased from $40 Million to over $4 Billion. His expertise lies in architecting and delivering full-fledge institutional operating platforms. Jason graduated Magna Cum Laude with a Bachelor of Business Administration in Finance and a Bachelor of Science in Economics with Business Honors and Department Distinction from Southern Methodist University. Jason has earned the Chartered Financial Analyst (CFA) designation. The CFA designation is regarded as one of the key investment professional certifications and is currently held by no more than 155,000 members worldwide.